A multicentre study to evaluate the effect of sulbactam/ampicillin combination on anaerobic micro-organisms.
Ampicillin combined with the beta-lactamase inhibitor sulbactam was compared with ampicillin alone, cefoxitin and metronidazole against 569 clinical strains of anaerobic organisms. The strains included 289 species of Bacteroides, 160 strains of Clostridium and 120 strains of various species of Streptococcus/Peptostreptococus, Fusobacterium, Veillonella, Eubacterium, Bifidobacterium, Actinomyces and Propionibacterium. Sulbactam/ampicillin was as effective as cefoxitin and metronidazole against all anaerobic species tested, inhibiting more than 90% of strains at the breakpoints (16, 32 and 32 mg/l, respectively). Sulbactam/ampicillin was also significantly more active than ampicillin against strains of Bacteroides, the minimal inhibitory concentration being at least four-fold lower. In contrast, the activity of the combination did not differ from that of ampicillin alone against Fusobacterium species and Gram-positive rods and cocci.
Institute of Microbiology, Catholic University of Sacro Cuore, A. Gemelli Clinic, Rome, Italy.
F
F
Leone
M G
MG
Morandotti
P
P
Mazzella
A
A
Sanna
G
G
Ravizzola
D
D
Colombrita
G
G
Pinzi
R
R
Turano
M G
MG
Menozzi
R
R
Lecchini
D000667:Ampicillin / Q000494:pharmacology*; D001421:Bacteria, Anaerobic / Q000187:drug effects* / Q000302:isolation & purification; D002440:Cefoxitin / Q000494:pharmacology*; D004347:Drug Interactions; D006090:Gram-Negative Bacteria / Q000187:drug effects; D006094:Gram-Positive Bacteria / Q000187:drug effects; D006801:Humans; D008795:Metronidazole / Q000494:pharmacology*; D008826:Microbial Sensitivity Tests; D015337:Multicenter Studies as Topic; D013407:Sulbactam / Q000494:pharmacology*
D008795:Metronidazole; D002440:Cefoxitin; D000667:Ampicillin; D013407:Sulbactam